Search Results

You are looking at 1 - 10 of 25 items for :

  • radiological surveillance x
Clear All
Open access

Ruth Therese Casey, Deborah Saunders, Benjamin George Challis, Deborah Pitfield, Heok Cheow, Ashley Shaw and Helen Lisa Simpson

malignancy, screening recommendations include annual radiological and biochemical surveillance ( 3 ). It is important to note, however, that recommended screening strategies are based on non-prospective data, and current clinical practice guidelines recommend

Open access

Logan Mills, Panagiotis Drymousis, Yogesh Vashist, Christoph Burdelski, Andreas Prachalias, Parthi Srinivasan, Krishna Menon, Corina Cotoi, Saboor Khan, Judith Cave, Thomas Armstrong, Martin O Weickert, Jakob Izbicki, Joerg Schrader, Andreja Frilling, John K Ramage and Raj Srirajaskanthan

radiological features, makes the case for surgery stronger at the present time. The aim of this study is to use a cohort of resected, non-functional, sporadic tumours from five centres that do not routinely adopt surveillance in order to characterise the

Open access

Nicola Tufton, Lucy Shapiro, Anju Sahdev, Ajith V Kumar, Lee Martin, William M Drake, Scott A Akker and Helen L Storr

F 18 12.0 11 mm Abdo PGL6 mm Abdo PGL 18.021 Normal a 9 years of follow up a Surveillance monitoring. No increase in size of PGL over 2 years. New 6 mm lesion on recent surveillance review with radiological characteristics of PGL

Open access

Hanbaro Kim, Ki Byung Song, Dae Wook Hwang, Jae Hoon Lee, Shadi Alshammary and Song Cheol Kim

analysis Preoperative radiological assessment included abdominal and pelvic computed tomography (CT) and, in selected cases, magnetic resonance imaging (MRI) of the pancreas, as well as the liver, if metastases or suspicious liver lesions were detected on

Open access

Giorgio Grani, Livia Lamartina, Vito Cantisani, Marianna Maranghi, Piernatale Lucia and Cosimo Durante

features but benign cytology) or presumably benign (nodules with no suspicious ultrasound features) and managed with active surveillance as long as there was no evidence of malignancy. The images had been acquired in our thyroid cancer unit at the time of

Open access

Benjamin G Challis, Andrew S Powlson, Ruth T Casey, Carla Pearson, Brian Y Lam, Marcella Ma, Deborah Pitfield, Giles S H Yeo, Edmund Godfrey, Heok K Cheow, V Krishna Chatterjee, Nicholas R Carroll, Ashley Shaw, John R Buscombe and Helen L Simpson

, pancytopenia developed following the fourth cycle requiring granulocyte-colony-stimulating factor and has been slow to improve. To date, 16 months following the first cycle of [ 177 Lu]-DOTATATE, radiological surveillance demonstrates reduction in size of the

Open access

Andrea Mazurat, Andrea Torroni, Jane Hendrickson-Rebizant, Harbinder Benning, Richard W Nason and K Alok Pathak

follow-up, and the final outcome status as of January 1, 2013 were recorded. Clinically and radiologically detectable disease relapses were considered as recurrences and a cytology/biopsy confirmation was obtained for local/regional relapses whenever it

Open access

Prachi Bansal, Anurag Lila, Manjunath Goroshi, Swati Jadhav, Nilesh Lomte, Kunal Thakkar, Atul Goel, Abhidha Shah, Shilpa Sankhe, Naina Goel, Neelam Jaguste, Tushar Bandgar and Nalini Shah

mortality ( 2 ). Transsphenoidal surgery (TSS) of pituitary adenoma is the primary treatment modality, with varying remission rates (52–96.6%) reported across different centres ( 3 ). Various demographic, biochemical, radiological and histopathological

Open access

Wafaa M Rashed, Anas Saad, Muneer Al-Husseini, Ahmed Mahmoud Galal, Assem Mohamed Ismael, Ahmed M Al-Tayep, Ayman El Shafie, Mahmoud Ahmed Ali and Ahmad Samir Alfaar

second malignant neoplasm (SMN) ( 4 ). We aim to report the incidence of the adrenal gland malignancies as a second primary malignancy based on the Surveillance, Epidemiology, and End Results ‘SEER’ database. Patients and methods We obtained data

Open access

Qianqian Pang, Yuping Xu, Xuan Qi, Yan Jiang, Ou Wang, Mei Li, Xiaoping Xing, Ling Qin and Weibo Xia

an important role in the development of tumors. PGE 2 can stimulate cell proliferation, angiogenesis and motility while inhibiting apoptosis and immune surveillance ( 8 , 9 , 10 ). Reduced 15-PGDH and SLCO2A1 are believed to contribute to elevated